| Financial Year |
March 31 2023 |
| Monetary Funds |
31,508,448,858.23 |
| Held-for-trading Financial Assets |
4,085,968,892.13 |
| Notes Receivable |
58,022,156.83 |
| Accounts Receivable |
15,140,320,592.15 |
| Advances to Suppliers |
23,935,318,745.63 |
| Other Receivables |
2,034,088,303.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
49,431,517,108.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
355,556,216.58 |
| Other Current Assets |
5,318,482,594.83 |
| Total Current Assets |
134,695,661,079.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
8,598,292,883.94 |
| Long-term Equity Investment |
3,200,272,805.54 |
| Investment Properties |
3,059,528,977.65 |
| Fixed Assetes |
10,962,763,520.54 |
| Under-construction Projects |
1,989,291,089.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
355,134.89 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,677,873,681.47 |
| R&D expenses |
44,830,492.87 |
| Goodwill |
1,901,355,731.31 |
| Long-Term Deferred and Prepaid Expenses |
569,258,214.13 |
| Deferred Income Tax Assets |
1,353,398,443.68 |
| Other Non-Current Assets |
384,043,464.44 |
| Sub-Total of Non-Current Assets |
44,597,937,836.68 |
| Total Assets |
179,293,598,915.88 |
| Short-Term Loans |
26,576,635,587.45 |
| Trading Financial liabilities |
410,842,685.36 |
| Notes Payable |
19,890,237,134.97 |
| Accounts Payable |
17,930,848,912.38 |
| Accounts Received In Advance |
675,419,578.34 |
| Employee Compensation Payable |
1,028,293,124.80 |
| Taxes Payable |
1,345,798,360.23 |
| Interest Payable |
-- |
| Dividend Payable |
7,585,679.45 |
| Other payables |
6,615,918,900.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
807,597,550.28 |
| Other Current Liabilities |
16,401,774,546.72 |
| Sub-Total of Current Liabilities |
117,724,962,199.86 |
| Long-term Loans |
3,102,200,942.60 |
| Bonds Payable |
6,810,616,788.78 |
| Long-Term Accounts Payable |
1,124,980,342.11 |
| Special Payable |
-- |
| Estimatied Liabilities |
105,373,613.59 |
| Deferred Income Tax Liabilities |
905,541,031.13 |
| Other Non-Current Liabilities |
566,796,319.59 |
| Sub-Total of Non-Current Liabilities |
13,777,344,104.11 |
| Total Liabilities |
131,502,306,303.97 |
| Paid-In Capital(Or Share Stock) |
5,194,872,040.00 |
| Capital Surplus |
8,315,815,158.73 |
| Surplus Reserve |
1,466,503,216.06 |
| LESS:Treasury Stock |
390,108,600.00 |
| Undistributed Profits |
17,280,052,583.21 |
| Minority Stockholder's Interest |
13,019,239,341.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
34,772,053,270.71 |
| Owner's Equity（Stockholder's Equity） |
47,791,292,611.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
179,293,598,915.88 |
